Lihe Kechuang: Lihe Yunji has not carried out experimental verification against monkeypox virus yet
Lihe Kechuang said on the interactive platform that Lihe Yunji has not carried out experimental verification against monkeypox virus yet. Liheyunji's self disinfection and sterilization anti-virus functional material has the advantages of efficacy durability, safety and broad-spectrum effectiveness, and has not been applied to the field of mask production.
This text is a result of machine translation.
Related companies：
Briefing Jun 10, 2022 02:09 PM
· Technology
Ningde times: the industrialization layout of sodium ion battery has been started, and a basic industrial chain will be formed in 2023
Briefing Jun 01, 2022 10:34 AM
· Consumer Staples
China Merchants Securities: maintain the "recommended" rating on Alibaba and look forward to the development prospect of global business
In-depth
Healthcare
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Briefing May 24, 2022 02:24 PM
· Healthcare
Zelensky called on the international community to provide funds for Ukraine's reconstruction, which is expected to cost $500 billion
Feb 28, 2026 11:13 AM
Jan 30, 2026 06:00 PM
May 11, 2023 05:07 PM
Jan 06, 2023 08:30 AM
Briefing May 21, 2022 06:44 AM
· Financials
913 companies have been investigated by public funds since the second quarter, and the six top flow fund managers focus on the leaders of subdivided industries
Automotive
XPeng Launches G6 and G9 in Mexico, First Authorized Stores to Open April 6
Recently, XPeng Motors (小鹏汽车) officially introduced its global models, the G6 and G9, to the Mexican market. This move represents a critical step in deepening its Latin American presence and marks a new milestone in its globalization strategy.
Yesterday 01:12 PM
Healthcare
Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab
The study data showed that compared to chemotherapy alone, toripalimab in combination with chemotherapy in the first-line treatment of patients with advanced NSCLC without EGFR/ALK mutations could significantly improve the PFS and the OS of patients with a manageable safety profile regardless of PD-L1 expression status.
Sep 20, 2022 03:35 PM
In-depth
Healthcare, Financials, Automotive · Analysis
Manufacturing Glass for the Automobile Industry: Fuyao Group
You may remember Fuyao from the 2019 Netflix documentary, 'American Factory.' While the documentary lays out the story of the Chinese company’s foray into America based on social issues, here you will find out about the business side.
May 27, 2020 07:45 PM
Briefing Apr 18, 2022 10:18 PM
· Technology
A number of enterprises on the science and innovation board are listed on the "white list" of key enterprises for operation guarantee and transfer
See more
Read next
Insight
In-depth
Automotive · Analysis
Investment Is Booming, Orders Are Rising, but Robots Are Still Learning How to Deliver
Mar 23, 2026 10:29 AM
Insight
In-depth
Automotive · Analysis
Thinking of ASEAN as a single market is the biggest miscalculation for Chinese companies
Feb 19, 2026 12:00 PM
Insight
In-depth
Communication, Consumer Staples, Industrials
You're Invited: China's Innovation, Up Close
Feb 10, 2026 04:21 PM
Insight
In-depth
Automotive · Analysis
CES 2026 in Numbers | From Shenzhen to Las Vegas: Huaqiangbei’s Year-End Report
Jan 15, 2026 09:42 PM